북미 및 유럽의 이국적 반려동물 시장 규모, 점유율 및 동향 분석 보고서 : 동물 유형별, 투여 경로별, 제품별, 적응증별, 유통 채널별, 지역별, 부문별 예측(2024-2030년)

Market Size & Trends:

The North America and Europe exotic companion animal market size was estimated at USD 1.30 billion in 2023 and is projected to grow at a CAGR of 7.9% from 2024 to 2030. The increasing pet humanization, rising medicalization rate, supportive R&D initiatives and the growing adoption of pet insurance coupled with combination of demographic trends and advancements in veterinary care is driving the market growth. According to the report published by PangoVet in May 2024, Approximately 17.6 million exotic pets are currently owned across 9 million American households. Among these, 26% are birds, and 51% are reptiles highlighting a substantial exotic pet population in the U.S.

As urbanization and apartment living become more prevalent, traditional pets like dogs and cats, which often require more space and care, are being supplemented by smaller, exotic species that are more suited to confined living spaces. Animals such as reptiles, birds, and small mammals like ferrets and hedgehogs are becoming popular choices, offering pet owners a sense of novelty and distinction. The rising awareness and acceptance of the therapeutic benefits of owning exotic pets also drives the market growth. Many studies have highlighted the psychological and emotional advantages of pet ownership, such as reduced stress and increased happiness.

According to the study published by National Institute of Health, animal interaction can reduce stress, lower blood pressure, and boost mood, while also reducing loneliness, increasing social support, and enhancing mood. This has led to a growing trend of acquiring exotic pets for companionship and mental health support. For instance, birds and reptiles are often praised for their calming presence and relatively low maintenance compared to more traditional pets. In addition, the increasing visibility of exotic pets in media and popular culture has normalized and even glamorized their ownership, further driving market demand.

Regulatory influences significantly impact the care and welfare of exotic animals, driving improvements in their treatment and increasing demand for veterinary services. In many regions, stringent regulations ensure pet owners provide proper nutrition, housing, and medical care. In the U.S., the USDA's Animal and Plant Health Inspection Service (APHIS) and the Office of Laboratory Animal Welfare (OLAW) are crucial in enforcing the Animal Welfare Act (AWA) and the Public Health Service (PHS) Policy.

These regulations set standards for humane treatment in various settings. Similarly, in the European Union, the Directorate-General for Health and Food Safety (DG SANTE) implements regulations like Directive 2010/63/EU, which governs the welfare of animals used in scientific research. The European Convention for the Protection of Pet Animals, a Council of Europe treaty, ensures pet welfare by setting standards for their breeding, care, keeping, and trade. These regulatory frameworks in both regions aim to uphold high standards of animal welfare through strict enforcement and oversight.

North America And Europe Exotic Companion Animal Market

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2018 to 2030. For the purpose of this report, Grand View Research has segmented the North America & Europe exotic companion animal market on the basis of by animal type, by route of administration, by product, by indication, by distribution channel and region.

• Animal Type Outlook (Revenue, USD Billion, 2018 - 2030)
• Small Mammals
• Birds
• Reptiles
• By Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
• Oral
• Topical
• Injectable
• By Product Outlook (Revenue, USD Billion, 2018 - 2030)
• Pharmaceuticals
  • Parasiticides
  • Antibacterial
  • Medicated Feed Additives
  • Others (Antiviral)
• Foods & Supplements
• Others
• By Indication Outlook (Revenue, USD Billion, 2018 - 2030)
• Bacterial infection
• Parasitic infection
• Orthopedic diseases
• Others
• By Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
• Veterinary Hospitals/Clinics
• Retail
• E-Commerce
• Regional Outlook (Revenue, USD Billion, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Animal Type
  • 1.2.2. By Route of Administration
  • 1.2.3. By Product
  • 1.2.4. By Indication
  • 1.2.5. By Distribution Channel
  • 1.2.6. Regional scope
  • 1.2.7. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Animal type Outlook
  • 2.2.2. By Route of Administration Outlook
  • 2.2.3. By Product Outlook
  • 2.2.4. By Indication Outlook
  • 2.2.5. By Distribution Channel Outlook
  • 2.2.6. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. North America & Europe Exotic Companion Animal Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
  • 3.2.5. Industry Analysis - Porter's
    • 3.2.5.1. Bargaining power of the suppliers
    • 3.2.5.2. Bargaining power of the buyers
    • 3.2.5.3. Threats of substitution
    • 3.2.5.4. Threats from new entrants
    • 3.2.5.5. Competitive rivalry
  • 3.2.6. PESTEL Analysis
    • 3.2.6.1. Political landscape
    • 3.2.6.2. Economic and Social landscape
    • 3.2.6.3. Technological landscape
• 3.3. Pricing Analysis
• 3.4. Regulatory framework
• 3.5. Estimated Animal Population By key species, key countries, 2023
• 3.6. COVID-19 Impact Analysis

Chapter 4. North America & Europe Exotic Companion Animal Market: Animal Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. North America & Europe Exotic Companion Animal Market: Animal Type Movement Analysis, 2023 & 2030 (USD Million)
  • 4.2.1. Small Mammals
    • 4.2.1.1. Small Mammals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.2.2. Birds
    • 4.2.2.1. Birds Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.2.3. Reptiles
    • 4.2.3.1. Reptiles Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5. North America & Europe Exotic Companion Animal Market: By Route of Administration Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. North America & Europe Exotic Companion Animal Market: By Route of Administration Movement Analysis, 2023 & 2030 (USD Million)
  • 5.2.1. Oral
    • 5.2.1.1. Oral Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.2.2. Topical
    • 5.2.2.1. Topical Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.2.3. Injectable
    • 5.2.3.1. Injectable Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6. North America & Europe Exotic Companion Animal Market: By Product Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. North America & Europe Exotic Companion Animal Market: By Product Movement Analysis, 2023 & 2030 (USD Million)
  • 6.2.1. Pharmaceuticals
    • 6.2.1.1. Pharmaceuticals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.1.2. Parasiticides
      • 6.2.1.2.1. Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.1.3. Antibacterial
      • 6.2.1.3.1. Antibacterial Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.1.4. Medicated Feed Additives
      • 6.2.1.4.1. Medical Feed Additives Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.1.5. Others (Antiviral)
      • 6.2.1.5.1. Others (Antiviral) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.2. Food & Supplements
    • 6.2.2.1. Food & Supplements Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.3. Others
    • 6.2.3.1. Other Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. North America & Europe Exotic Companion Animal Market: By Indication Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. North America & Europe Exotic Companion Animal Market: By Indication Movement Analysis, 2023 & 2030 (USD Million)
  • 7.2.1. Bacterial Infection
    • 7.2.1.1. Bacterial Infection Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.2.2. Parasitic Infection
    • 7.2.2.1. Topical Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.2.3. Orthopedic Diseases
    • 7.2.3.1. Orthopedic Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.2.4. Others
    • 7.2.4.1. Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. North America & Europe Exotic Companion Animal Market: By Distribution Channel Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. North America & Europe Exotic Companion Animal Market: By Distribution Channel Movement Analysis, 2023 & 2030 (USD Million)
  • 8.2.1. Veterinary Hospitals/ Clinics
    • 8.2.1.1. Veterinary Hospital/ Clinics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.2.2. Retail
    • 8.2.2.1. Retail Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.2.3. E-commerce
    • 8.2.3.1. E-commerce Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. North America & Europe Exotic Companion Animal Market: Regional Estimates & Trend Analysis

• 9.1. Regional Market Share Analysis, 2023 & 2030
• 9.2. Regional Market Dashboard
• 9.3. Global Regional Market Snapshot
• 9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 9.5. North America
  • 9.5.1. U.S.
    • 9.5.1.1. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.2. Canada
    • 9.5.2.1. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 9.6. Europe
  • 9.6.1. UK
    • 9.6.1.1. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.2. Germany
    • 9.6.2.1. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.3. France
    • 9.6.3.1. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.4. Italy
    • 9.6.4.1. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.5. Spain
    • 9.6.5.1. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.6. Norway
    • 9.6.6.1. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.7. Sweden
    • 9.6.7.1. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.8. Denmark
    • 9.6.8.1. Denmark market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Company Participant Categorization
• 10.2. Company Market Position Analysis/ Heap Map Analysis
• 10.3. Company Profile
  • 10.3.1. AdvaCare Pharma
    • 10.3.1.1. Company overview
    • 10.3.1.2. Financial performance
    • 10.3.1.3. Product benchmarking
    • 10.3.1.4. Strategic initiatives
  • 10.3.2. Merck & Co., Inc.
    • 10.3.2.1. Company overview
    • 10.3.2.2. Financial performance
    • 10.3.2.3. Product benchmarking
    • 10.3.2.4. Strategic initiatives
  • 10.3.3. VETARK (Candioli Srl)
    • 10.3.3.1. Company overview
    • 10.3.3.2. Financial performance
    • 10.3.3.3. Product benchmarking
    • 10.3.3.4. Strategic initiatives
  • 10.3.4. Vetafarm
    • 10.3.4.1. Company overview
    • 10.3.4.2. Financial performance
    • 10.3.4.3. Product benchmarking
    • 10.3.4.4. Strategic initiatives
  • 10.3.5. VioVet Ltd (Pethealth)
    • 10.3.5.1. Company overview
    • 10.3.5.2. Financial performance
    • 10.3.5.3. Product benchmarking
    • 10.3.5.4. Strategic initiatives
  • 10.3.6. Mazuri
    • 10.3.6.1. Company overview
    • 10.3.6.2. Financial performance
    • 10.3.6.3. Product benchmarking
    • 10.3.6.4. Strategic initiatives
  • 10.3.7. Earth Paws Private Limited.
    • 10.3.7.1. Company overview
    • 10.3.7.2. Financial performance
    • 10.3.7.3. Product benchmarking
    • 10.3.7.4. Strategic initiatives
  • 10.3.8. Versele Laga
    • 10.3.8.1. Company overview
    • 10.3.8.2. Financial performance
    • 10.3.8.3. Product benchmarking
    • 10.3.8.4. Strategic initiatives
  • 10.3.9. CROCdoc
    • 10.3.9.1. Company overview
    • 10.3.9.2. Financial performance
    • 10.3.9.3. Product benchmarking
    • 10.3.9.4. Strategic initiatives
  • 10.3.10. Zoetis
    • 10.3.10.1. Company overview
    • 10.3.10.2. Financial performance
    • 10.3.10.3. Product benchmarking
    • 10.3.10.4. Strategic initiatives
  • 10.3.11. Vetnil
    • 10.3.11.1. Company overview
    • 10.3.11.2. Financial performance
    • 10.3.11.3. Product benchmarking
    • 10.3.11.4. Strategic initiativesa
• 10.4. Strategy Mapping
  • 10.4.1. Mergers & Acquisitions
  • 10.4.2. Partnerships & Collaborations
  • 10.4.3. Expansion
  • 10.4.4. Product launch
  • 10.4.5. Others
• 10.5. List of other Key players